Allogene is ceasing enrollment in a Phase I trial of cema-cel for patients with relapsed or refractory chronic lymphocytic ...

UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer ...

The U.S. does fund bio labs in Ukraine, however, her detractors said at the time that she insinuated the U.S. is also funding ...

Zai Lab announces $200M share offering amid 47% revenue growth and plans for KarXT submission in China. Multiple companies report changes: Kronos Bio seeks alternatives, Allogene halts trial ...

Tulsi Gabbard, a former fringe Democrat turned Trump loyalist, was tapped by Donald Trump as the next National Intelligence ...

On Wednesday, BridgeBio Pharma Inc (BBIO) stock saw a modest uptick, ending the day at $24.79 which represents a slight increase of $0.17 or 0.69% from the prior close of $24.62. The stock opened at ...

Lonza, WuXi Biologics, and Baxter Healthcare announce facility expansions and updates. Repligen reports revenue growth, while ...

The New England Patriots have received great news as they come off their road win over the Chicago Bears and prepare to face ...